golimumab,guselkumab
janssen
['vega']
promising combination trial results in vega: tnf (gol) vs il-23 (gus) vs combo induction &gt; gus. combo &gt; mono for induction. later time pt combo &gt;gus &gt; gol. trying to raise the ceiling. #acg2022 
Clinical Director of Translational Research, Jill Roberts Center for #IBD @nyphospital @WeillCornell Tweets are mine but not = endorsement or medical advice.